705 related articles for article (PubMed ID: 15605181)
41. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
St-Germain G; Laverdière M; Pelletier R; Bourgault AM; Libman M; Lemieux C; Noël G
J Clin Microbiol; 2001 Mar; 39(3):949-53. PubMed ID: 11230409
[TBL] [Abstract][Full Text] [Related]
42. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
[TBL] [Abstract][Full Text] [Related]
43. Molecular epidemiology of Candida species isolated from urine at an intensive care unit.
Ergon MC; Gülay Z
Mycoses; 2005 Mar; 48(2):126-31. PubMed ID: 15743431
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: a case-control study.
Garzillo C; Bagattini M; Bogdanović L; Di Popolo A; Iula VD; Catania MR; Raimondi F; Triassi M; Zarrilli R
Ital J Pediatr; 2017 Jan; 43(1):10. PubMed ID: 28257640
[TBL] [Abstract][Full Text] [Related]
45. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia.
Tumbarello M; Posteraro B; Trecarichi EM; Fiori B; Rossi M; Porta R; de Gaetano Donati K; La Sorda M; Spanu T; Fadda G; Cauda R; Sanguinetti M
J Clin Microbiol; 2007 Jun; 45(6):1843-50. PubMed ID: 17460052
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
Nace HL; Horn D; Neofytos D
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.
Pemán J; Cantón E; Linares-Sicilia MJ; Roselló EM; Borrell N; Ruiz-Pérez-de-Pipaon MT; Guinea J; García J; Porras A; García-Tapia AM; Pérez-Del-Molino L; Suárez A; Alcoba J; García-García I
J Clin Microbiol; 2011 Dec; 49(12):4158-63. PubMed ID: 22012014
[TBL] [Abstract][Full Text] [Related]
48. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
Małafiej E; Adamiec AC; Tworzyańska U
Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
[TBL] [Abstract][Full Text] [Related]
49. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
[TBL] [Abstract][Full Text] [Related]
51. [Risk factors associated with colonization by Candida spp in neonates hospitalized in a Neonatal Intensive Care Unit in Brazil].
Borges RM; Soares LR; de Brito CS; de Brito DV; Abdallah VO; Filho PP
Rev Soc Bras Med Trop; 2009; 42(4):431-5. PubMed ID: 19802481
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.
Pemán J; Cantón E; Gobernado M;
Eur J Clin Microbiol Infect Dis; 2005 Jan; 24(1):23-30. PubMed ID: 15619060
[TBL] [Abstract][Full Text] [Related]
53. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.
Colombo AL; Nucci M; Park BJ; Nouér SA; Arthington-Skaggs B; da Matta DA; Warnock D; Morgan J;
J Clin Microbiol; 2006 Aug; 44(8):2816-23. PubMed ID: 16891497
[TBL] [Abstract][Full Text] [Related]
54. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
55. Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections.
Asmundsdóttir LR; Erlendsdóttir H; Haraldsson G; Guo H; Xu J; Gottfredsson M
Clin Infect Dis; 2008 Jul; 47(2):e17-24. PubMed ID: 18549311
[TBL] [Abstract][Full Text] [Related]
56. Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran.
Charsizadeh A; Mirhendi H; Nikmanesh B; Eshaghi H; Makimura K
Mycoses; 2018 Jan; 61(1):22-29. PubMed ID: 28872714
[TBL] [Abstract][Full Text] [Related]
57. Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000.
Dóczi I; Dósa E; Hajdú E; Nagy E
J Med Microbiol; 2002 Aug; 51(8):677-681. PubMed ID: 12171299
[TBL] [Abstract][Full Text] [Related]
58. [Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility].
França JC; Ribeiro CE; Queiroz-Telles Fd
Rev Soc Bras Med Trop; 2008; 41(1):23-8. PubMed ID: 18368266
[TBL] [Abstract][Full Text] [Related]
59. Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades.
Safdar A; Perlin DS; Armstrong D
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):11-6. PubMed ID: 12376025
[TBL] [Abstract][Full Text] [Related]
60. Antifungal susceptibilities of Candida species isolated from urine culture.
Toka Özer T; Durmaz S; Yula E
J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
